Attention-Deficit Hyperactivity Disorder
Download
Report
Transcript Attention-Deficit Hyperactivity Disorder
Attention-Deficit Hyperactivity
Disorder
By
Chris Golner
April 19, 1999
Biochemistry/Molecular Biology Seminar
ADHD Statistics
3-5% of all U.S. school-age children are
estimated to have this disorder.
5-10% of the entire U.S. population
Males are 3 to 6 times more likely to have
ADHD than are females.
At least 50% of ADHD sufferers have
another diagnosable mental disorder.
Outline
History of ADHD
Symptoms and Diagnosis: DSM-IV criteria
Possible causes
Treatments
Stimulants
Outcome
History of ADHD
Mid-1800s: Minimal Brain Damage
Mid 1900s: Minimal Brain Dysfunction
1960s: Hyperkinesia
1980: Attention-Deficit Disorder
With
or Without Hyperactivity
1987: Attention Deficit Hyperactivity Disorder
1994-present: ADHD
Primarily
Inattentive
Primarily
Hyperactive
Combined Type
Diagnosing ADHD: DSM-IV
Inattentiveness:
Has a minimum of 6
symptoms regularly for
the past six months.
Symptoms are present at
abnormal levels for stage
of development
Lacks attention to detail;
makes careless mistakes
has difficulty sustaining
attention
doesn’t seem to listen
fails to follow through/fails
to finish projects
has difficulty organizing
tasks
avoids tasks requiring
mental effort
often loses items necessary
for completing a task
easily distracted
is forgetful in daily activities
Diagnosing ADHD: DSM-IV
Hyperactivity/
Impulsivity:
Has a minimum of 6
symptoms regularly for the
past six months.
Symptoms are present at
abnormal levels for stage of
development
Fidgets or squirms
excessively
leaves seat when
inappropriate
runs about/climbs
extensively when
inappropriate
has difficulty playing
quietly
often “on the go” or “driven
by a motor”
talks excessively
blurts out answers before
question is finished
cannot await turn
interrupts or intrudes on
others
Diagnosing ADHD: DSM-IV
Additional
Criteria:
Symptoms causing impairment
present before age 7
Impairment from symptoms
occurs in two or more settings
Clear evidence of significant
impairment (social, academic,
etc.)
Symptoms not better accounted
for by another mental disorder
Problems of Diagnosis
Subjectivity of Criteria
Inconsistent evaluations--presence of
symptoms usually given by teacher or parent
Study by Szatmari et al (1989) showed that the
number of diagnosed cases of ADHD
decreased 80% when observations of parent,
teacher and physician were used rather than
just one source
Symptoms in females more subtle---leads to
underdiagnosis
ADHD and the Brain
Diminished arousal of
the Nervous System
Decreased blood flow
to prefrontal cortex
and pathways
connecting to limbic
system (caudate
nucleus and striatum)
PET scan shows
decreased glucose
metabolism
throughout brain
Comparison of normal brain (left) and brain
of ADHD patient.
ADHD and the Brain II
Similarities of ADHD symptoms to those from
injuries and lesions of frontal lobe and
prefrontal cortex
MRIs of ADHD patients show:
Smaller anterior right frontal lobe
abnormal
development in the frontal and striatal regions
Significantly smaller splenium of corpus callosum
decreased
communication and processing of
information between hemispheres
Smaller caudate nucleus
What causes ADHD?
Underlying cause of these differences is still
unknown; there is much conflicting data between
studies
Strong evidence of genetic component
Predominant theory: Catecholamine
neurotransmitter dysfunction or imbalance
decreased dopamine and/or norepinephrine
uptake in brain
theory supported by positive response to
stimulant treatment
Recent study indicates possible lack of serotonin
as a factor in mice
Dopamine in the Brain
Scientific American
Http//www.sciam.com/1998/0998issue/0998barkely.html#link1
Genetic Linkages to ADHD
Twin studies by Stevenson, Levy et al, and
Sherman et al indicate an average heritability
factor of .80
Biederman et al reported a 57% risk to offspring if
one parent has ADHD.
Dopamine genes
DA type 2 gene
DA transporter gene (DAT1)
Dopamine receptor (DRD4, “repeater gene”) is
over-represented in ADHD patients
DRD4
DRD4 is most likely contributor
DRD4 affects the post-synaptic sensitivity
in the prefrontal and frontal cortex
This region of cortex affects executive
functions and attention
Executive functions include working
memory, internalization of speech,
emotions, motivation, and learning of
behavior
Treatment
Counseling of individual and family
Stimulants
Tricyclic antidepressants
Bupropion
Clonidine
Stimulants
Exact mechanism unknown
Raise activity level of the CNS by decreasing
fluctuations of activity or lowering threshold
needed for arousal
Similar in structure to NE and DA, and may
mimic their actions
At least 75% have positive response with
single dose
95% respond well to stimulant treatment
Include methylphenidate, dextroamphetamine
and pemoline
Methylphenidate
Is a piperidine
derivative commonly
known as Ritalin®
Is believed to act as
dopamine agonist in
synaptic cleft
Stimulates frontalstriatal regions
Dosage (5-20 mg) must
be adjusted to each
patient
Taken orally, 2-3 times
a day as needed
Behavioral effects start
within 1/2 hour to hour
after ingestion, peaking
at 1 and 3 hours
Also comes in
Sustained-Release
form, whose effects last
approximately twice as
long.
Effects of MPH
Elevates mood
Raises arousal of CNS and cerebral blood
flow
Increases productivity
Improves social interactions
Increases heart rate and blood pressure
Has little or no abuse potential
Side Effects
Common:
decreased appetite
insomnia
behavioral
rebound
head and stomach
aches
Mild:
Rare:
Also thought to cause
temporary height and
weight suppression
anxiety/
depression
irritability
tics (Tourette’s
Syndrome)
overfocussing
liver problems or
rash (Pemoline
only)
Outcome
ADHD can persist into adulthood, but usually
symptoms gradually diminish
When it persists into adulthood, it usually
requires ongoing treatment and counseling
most will develop another disorder (especially
learning disability, ODD, depression, and/or
conduct disorder)
Without treatment:
antisocial and deviant behavior
increased rates of divorce, moving violations,
incarceration, and institutionalization
References
Barkley, R. Attention-Deficit Hyperactivity Disorder, 2nd Ed. New York: Guilford Press. 1998. 628
pp.
Shaywitz, B. and Shaywitz, S. Attention Deficit Disorder Comes of Age: Toward the 21st Century.
Austin, TX: Hammill Foundation. 1992. 366 pp.
Rie, H.E. and Rie, E.D., Eds. Handbook of Minimal Brain Dysfunctions: A Critical View. New
York: John Wiley & Sons. 1980. 744 pp.
Faigel, H. Attention Deficit Disorder: A Review. J. of Adolesc. Health, Mar 1995 Vol. 16: 174-84.
Cantwell, D.P. Attention Deficit Disorder: A Review of the Past Ten Years. J. of the Am. Acad. Of
Child Adolesc. Psychiatry. 1996, Vol 35: 978-87.
Seideman, L., Biederman, J., and Faraone, S.V. A Pilot Study of Neuropsychological Function in
Girls with ADHD. J. of Am. Acad. of Child Adolesc. Psychiatry, 1997. Vol. 36: 366-73.
Seideman, L., Biederman, J., and Faraone, S.V. A Pilot Study of Neuropsychological Function in
Girls with ADHD. J. of Am. Acad. of Child Adolesc. Psychiatry, 1997. Vol. 36: 366-73.
References
Levy, F., Hay D.A., McStephen, M., Wood, C., and Waldman, I. Attention-Deficit Hyperactivity
Disorder: A Category or Continuum? Genetic Analysis of a Large Scale Twin Study. J. of Am.
Acad. Of Child Adolesc. Psychiatry, 1997, Vol 36: 737-44.
Sherman, D.K., Iacono, W.G., McGue, M.K. Attention-Deficit Hyperactivity Disorder Dimensions:
A Twin Study of Inattention and Impulsivity-Hyperactivity. J. of Am. Acad. Of Child Adolesc.
Psychiatry, 1997, Vol 36: 737-44.
Scientific American Online: http://www.sciam.com/1998/0998issue/0998barkley.html#link1
Ritalin Action on Hyperactivity Explained By New Theory
http://pharmacology.tqn.com/library/99news/bl9n0155d.htm
Approaching a Scientific Understanding of what Happens in the Brain in AD/HD
http://www.chadd.org/attnv4n1p30.htm
Marx, J. How Stimulant drugs May Clam Hyperactivity. Science, 1999, Vol. 283: 306-08.
http://www.sciencemag.org/cgi/content/full/283/5400/306?maxtoshow=&HITS=10&hits=10&RES
ULTFORMAT=&fulltext=Attention+Deficit+Disorder&searchid=QID_NOT_SET&FIRSTIND
EX=